Macrilen is a Oral Granule, For Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Macimorelin.
Product ID | 0169-1401_5f3f501c-3f74-44ba-bc9c-7a9ee78576b3 |
NDC | 0169-1401 |
Product Type | Human Prescription Drug |
Proprietary Name | Macrilen |
Generic Name | Macimorelin Acetate |
Dosage Form | Granule, For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-01-31 |
Marketing Category | NDA / |
Application Number | NDA205598 |
Labeler Name | Novo Nordisk |
Substance Name | MACIMORELIN |
Active Ingredient Strength | 60 mg/mg |
Pharm Classes | Growth Hormone Secretagogue Receptor Agonist [EPC], Growth Hormone Secretagogue Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2022-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0169-1401 | Macrilen | Macimorelin acetate |
71090-002 | Macrilen | Macimorelin acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MACRILEN 87978806 5624293 Live/Registered |
AETERNA ZENTARIS GMBH 2017-09-08 |
MACRILEN 87601284 not registered Live/Pending |
AETERNA ZENTARIS GMBH 2017-09-08 |
MACRILEN 87222769 5813944 Live/Registered |
AEterna Zentaris GmbH 2016-11-01 |
MACRILEN 86213980 not registered Dead/Abandoned |
AETERNA ZENTARIS GMBH 2014-03-07 |
MACRILEN 86213977 not registered Dead/Abandoned |
AETERNA ZENTARIS GMBH 2014-03-07 |
MACRILEN 86005271 not registered Dead/Abandoned |
AEterna Zentaris GmbH 2013-07-09 |